HBOT - Harch Hyperbarics
HBOT - Harch Hyperbarics  - Healing New Orleans With Pure Oxygen!
English Translate into French Translate into German Translate into Spanish Translate into Italian Translate into Japanese Translate into Hindi Translate into Korean Translate into Dutch Translate into Hebrew Translate into Swedish Translate into Chinese (Simplified) Translate into Rusian

Hyperbaric Oxygen Therapy

Dr. Paul Harch to Present HBOT at BIALA's Featured Speakers Tour May 17th 2012

From 4:00 PM to 6:00 PM

 

Dr. Paul Harch will be the first to present in BIALA's exciting new program "BIALA's Featured Speakers Tour." Located at:

The Louisiana Humanities Center
927 Lafayette Street

New Orleans, LA 70113

The first hour will be a Meet and Greet with Dr. Harch.   Here you can ask questions and learn more about his innovative approaches to brain injury with the use of Hyperbaric Oxygen (HBOT).


Guest List Admission Available Call 504 309-4948

 


A SPECIAL THANKS GOES OUT TO JOHN SALCEDO FOR THIS VIDEO PRODUCTION!

 

The Hyperbaric Chamber: Science, Not Miracle

 

By Nina Subbotina. MD, Ph.D

Nina Subbotina M.D., Ph.D is a specialist in hyperbaric medicine. She is the author of the first scientific book about this specialty written in Spanish: Medicina Hiperbárica.  Here is a first look at her latest book The Hyperbaric Chamber: O2 Science Not Miracle.

 

The Hyperbaric Chamber: O₂ Science, Not Miracle by Nina Subbotina M.D. Author: Nina Subbotina MD, Ph.D. Specialist in hyperbaric medicine and director of Buenos Aires Center of Hyperbaric Medicine since 1998.

·    A comprehensible exposition for health care professionals readily accessible to the general reader.

·   Describes treatments officially recognized in United States for 13 pathologies.

·   Describes treatments endorsed by evidence-based medicine and the current state of knowledge for many other pathologies.

 

The Hyprbaric Chamber: Science, Not Miracle, is a comprehensible exposition readily accessible to the general reader, of the principal applications of hyperbaric oxygen therapy, its technique, and its results.

   Contents
• Oxygen and the Hyperbaric Chamber
• Chronic Wounds or Nonhealing Ulcers
• Diabetic Foot Ulcer
• Gas Gangrene and Others Infections
• Severe Trauma
• República de Cromagnon’s Tragedy:
  Smoke and Toxic Gases
• Radiation Necrosis
• Aseptic Bone Necrosis
• Sudden Deafness and Acoustic Trauma
• Neurological Disorders
• Children with Autism
• Cerebral Palsy
• Contraindications, Side Effects
  and Complications
• Anti-Aging

 

 

The Oxygen Cure

Helps Treat Infection, Burns, Stroke, Autism, Migraine,
 and MoreWhat is Hyperbaric Oxygen Therapy? Click Here

 

By Dr. Paul Harch

 
What do flesh-eating bacteria, diabetic foot ulcers and carbon monoxide poisoning have in common?
They all are on the list of 13 medical conditions approved for treatment with hyperbaric oxygen therapy (HBOT)-breathing 100% oxygen under pressure while fully enclosed in a hyperbaric oxygen chamber. And there are many other conditions not yet officially approved that can benefit from the way HBOT treats disease.
HBOT is best known as a treatment for scuba divers with decompression sickness, or "the bends'' -when nitrogen bubbles form in the blood and other tissues. HBOT works partly by compressing those bubbles and dissolving them.
 

13 APPROVED USES FOR HYPERBARIC OXYGEN THERAPY (HBOT)

 
In the 1960s, doctors in the Netherlands discovered that HBOT could treat a life-threatening infection called gas gangrene, which can occur after severe wounds, such as those from gunshots and car accidents. The oxygen kills the anaerobic (nonoxygen-using) bacteria that cause the infection.
In 1965, Japanese doctors used HBOT to treat carbon monoxide poisoning from a coal mine fire. The oxygen displaces the carbon monoxide that is stuck to red blood cells.
The doctors also found that burns healed faster among patients treated with HBOT, generating another use for the therapy. Oxygen can reduce the secondary inflammatory reaction that accompanies any injury-the activation of the immune system's white blood cells and their subsequent discharge of toxic chemicals and enzymes, which further damages tissue.
The Undersea and Hyperbaric Medical Society (UHMS)-an organization representing physicians, nurses and technicians in the field of hyperbaric medicine-met with the Food and Drug Administration (FDA) and recommended HBOT for 13 specific conditions. These conditions are eased or aggravated by reduced oxygen level in body tissue. More than 30 years later, those approved conditions remain much the same:

VFW Supports HBOT Rehab for Brain InjuryHyperbaric Oxygen Therapy Rehab for Brain Injury is Included as the VFW Reiterates High Priority Issues

 
In a testimony to the Committees of Veteran’s Affairs given by, Commander-in-Chief of Veteran of Foreign Wars (VFW) D.C., Richard L. Eubank included positive statements concerning Hyperbaric Oxygen Therapy (HBOT) rehab for brain injury to treat veterans who have suffered a traumatic brain injury (TBI). These two paragraphs can be found in “STATEMENT OF RICHARD L. EUBANK COMMANDER-IN-CHIEF VFW TUESDAY, MARCH 8, 2011.” We believe this positive statement can help in our efforts to make HBOT a standard of care for TBI in America.
VFW Commander-in-Chief Richard L. Eubank writes:
“[The Committees on Veteran’s Affairs] VA must also continue its research into the effects of TBI on the brain. Research has made clear that undiagnosed cognitive or psychosocial conditions are far more debilitating than physical injuries, particularly with regard to employability. The follow-on effects of undiagnosed TBI can lead to a lifetime of unreached potential, and VA must work hard to ensure that effective treatments are readily available to help veterans avoid idleness. Veterans want to be useful and productive members of society after their military service is over, regardless of their physical condition. VA must help veterans affected with a brain injury achieve that goal by thoroughly evaluating all potential methods of care, such as Hyperbaric Oxygen Therapy and acupuncture, and incorporate those that prove to be effective into treatment regimens. . . . .

Hyperbaric Oxygenation in the Treatment of Patients with
Drug Addiction, Narcotic Addiction and Alcoholism
 in the Post-Intoxication and Abstinence Periods

 
[Original Article in Russian]
Epifanova NM.

HBOT in the Management of Cerebral Palsy

Virginia Neubauer, Richard Neubauer and Paul Harch

 

An entry from K.K. Jain's Textbook Of Hyperbaric Medicine

Cerebral palsy is a chronic neurological disorder that can be due to several causes of brain damage in utero, in the perinatal period, or postnatally. Hyperbaric oxygen has been shown to be useful in treating children with cerebral palsy. This topic is discussed under following headings:
Causes of Cerebral Palsy
Oxygen Therapy in the Neonatal Period
Treatment of Cerebral Palsy with HBOT
Conclusions

 

Causes of Cerebral Palsy
 

The term cerebral palsy (CP) covers a group of non-progressive, but often changing, motor impairment syndromes secondary to lesions or anomalies of the brain arising in the early stages of development. Between 20 to 25 of every 10,000 live-born children in the Western world have the condition (Stanley et al 2000). Problems may occur in utero, perinatal, and postnatal. Infections, traumatic brain injury, near-drowning and strokes in children suffering from neurological problems come under the heading of cerebral palsy. Diagnosis of cerebral palsy resulting from in utero or early perinatal causes may be made immediately after birth, but more commonly occurs between 15 and 24 months. It is possible that CP may be misdiagnosed for years because specific symptoms may show up very late in childhood. Some of the possible causes of Cerebral Palsy and are listed in Table 21.1.
Although several antepartum causes have been described for CP, the role of intrapartum asphyxia in neonatal encephalopathy and seizures in term infants is not clear. There is no evidence that brain damage occurs before birth. A study using brain MRI or post-mortem examination was conducted in 351 full-term infants with neonatal encephalopathy, early seizures, or both to distinguish between lesions acquired antenatally and those that developed in the intrapartum and early postpartum period (Cowan et al 2003). Infants with major congenital malformations or obvious chromosomal disorders were excluded. Brain images showed evidence of an acute insult without established injury or atrophy in (80%) of infants with neonatal encephalopathy and evidence of perinatal asphyxia. Although the results cannot exclude the possibility that antenatal or genetic factors might predispose some infants to perinatal brain injury, the data strongly suggest that events in the immediate perinatal period are most important in neonatal brain injury. These findings are important from management point of view as HBOT therapy in the perinatal period may be of value in preventing the evolution of cerebral palsy.

HBOT Therapy in Global Cerebral Ischemia Anoxia and Coma

 
Paul G. Harch and Richard A. Neubauer

 An entry from K.K. Jain's Textbook Of Hyperbaric Medicine

Hyperbaric oxygen therapy has been used in a number of conditions characterized by global ischemia (as opposed to focal ischemia of stroke), and anoxia, and leading to impairment of consciousness. Conditions such as coma due to brain injury and anoxia associated with drowning and hanging are discussed under the following headings:
 

 

Introduction


For a discussion of the effectiveness of hyperbaric oxygen (HBOT) therapy in global cerebral ischemia/anoxia and coma, we define HBOT as a medical treatment that uses high pressure oxygen as a drug by fully enclosing a person or animal in a pressure vessel and then adjusting the dose of the drug to treat pathophysiologic processes of the diseases. Like all drugs, the dose of HBOT is crucial and should be customized to each patient's response. It is dictated by the pathological target and is determined by the pressure of oxygen, duration of exposure, frequency, total number of treatments, and timing of the dose in the course of the disease. As diseases and their pathologies evolve, different doses of HBOT are required at different times. In addition, patients have individual susceptibility to drugs, manifest side effects and toxicity. Unfortunately, the ideal dose of HBOT in acute or chronic global ischemia/anoxia and coma is unknown. The studies reviewed below suggest higher pressures (2 ATA or higher) and lesser numbers of treatments very early in the disease process whereas lower pressures (2 ATA or lower) and a greater number of treatments have been used as the brain injury matures. While this general trend seems justified, the absolute or effective pressures delivered to the patients in these reports may be slightly less than what is stated since many studies do not specify the HBOT delivery system that was employed. For example, an oxygen pressurized chamber has an effective HBOT pressure equal to the plateau pressure administered during the treatment, whereas an air pressurized chamber in which oxygen is administered by aviators mask can achieve a far lower effective HBOT pressure, depending on the fit of the mask and the amount of its air/oxygen leak. In the later cases, the dose of oxygen is less. This concept is particularly important when analyzing the studies in this chapter performed prior to the late 1980s when the aviator mask dominated delivery systems in multiplace chambers.
 
 

Hyperbaric Oxygen Therapy Treatment eyed for PTSD/TBI

From: The American Legion - Washington Conference
By Steve B. Brooks - March 20, 2011

Dr. Paul Harch gives a presentation of the use of hyperbaric oxygen chambers to treat post-traumatic stress disorder and traumatic brain injuries to the Legion's PTS-TBI Ad-Hoc Committee. Photo by Steve B. BrooksDr Paul Harch of Harch Hyperbarics Inc. offers HBOT treatment for an injury to the brain

 

 Lay Interpretation of Preliminary Data in LSU IRB #7051 TBI/PTSD HBOT Pilot Trial:
 Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post-Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)-Pilot Trial

 

Paul G. Harch 1, Susan R. Andrews1, Edward Fogarty2, Juliette Lucarini1, Claire Aubrey1, Paul K. Staab1, Keith W. Van Meter1 1Louisiana State University School of Medicine, United States, 2University of North Dakota School of Medicine, United States 

The preliminary data from the LSU IRB #7051 TBI/PTSD HBOT Pilot Trial of Hyperbaric oxygen therapy in blast-induced chronic traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) represents the first organized body of information that suggests a significant treatment effect on the conditions that present the greatest challenge to the integrity of our armed forces. The Rand Report of 1/2008 indicated that X% of our military that have served in Iraq and Afghanistan have been injured or affected by TBI or PTSD. Traditional treatment is protracted counseling and unapproved use of psychoactive drugs that have significant side effects such as increased suicide rates. Epidemic suicide rates in veterans are consistent with the use of such medications. In this seminal report at the 8th World Congress on Brain Injury Harch and colleagues from LSU School of Medicine, New Orleans demonstrated significant improvements in cognition, symptoms, and quality of life in 15 U.S. veterans with TBI and PTSD an average 3 years after their injury.

The physicians and researchers showed that with 4 weeks of treatment using a low dose of hyperbaric oxygen therapy, a treatment used for nearly 100 years in divers and 50 years for wounds, they were able to treat these wounds in the brains of injured U.S. servicemen. Specifically, the veterans achieved improvements in memory, concentration, executive function, and quality of life, and a reduction in headaches, concussion symptoms, depression, and anxiety. The average veteran experienced an increase in IQ of 15 points, a nearly 35 percentile increase. Other cognitive changes averaged 25 percentile point increases while quality of life measures, concussion symptoms, depression and anxiety indices, and the veterans' estimates of their cognitive, physical, and emotional improvements improved by 30-90%. Surprisingly, the veterans showed a 30% reduction in PTSD symptoms. While the study did not include a control group, the magnitude of the improvement measured was striking and never before reported in the medical literature. Moreover, the data was supported by functional imaging data and very similar to a previous study by Harch where HBOT improved memory and blood vessel density in an animal model of traumatic brain injury. Equally importantly, in both the case reports and the LSU pilot study there were no significant side effects to the treatment. The scientific report at the International Brain Injury Association's 8th World Congress reaffirmed earlier published peer-reviewed case reports of Harch and USAF Col. Jim Wright on brain injured U.S. servicemen.

The implication of this preliminary study is that U.S. veterans with the same conditions can safely begin treatment with this established modality, HBOT, by physician direction privately or under a national program approved by Western Institutional Review Board. This program, the National Brain Injury Recovery and Rehabilitation Project (N-BIRR) will incorporate the latest statistical design methodology that is favored by the FDA, the Bayesian Method, to accumulate further scientific proof of HBOT treatment for these two diagnoses. The program will consist of delivery of the same Harch HBOT protocol in one or two blocks; there will be no placebo group. The researchers hope to see this larger trial confirm the exciting preliminary results of the LSU pilot trial and the case reports.

 

 

A proud mother, Cynthia

 

My son was shaken 21 years ago. He sustained severe head trauma, lost the sight in his dominant eye, he has balance difficulties, and an IQ of 50. We have tried numerous therapies, including music therapy at a university and private lessons, intensive speech therapy, exercise Therapy, two extra tutoring schools, a private tutor for 10 years, and neuro feedback. I’m sure some of these helped because he now is an excellent driver, holds a part-time job as a service clerk in a grocery store, is taking web computer classes at the local community college.

His father helps him with the computer classes and was a major driving force that helped our son become an Eagle Scout. My husband and I are 59 & 60 and are very nervous about the future of our son when we are gone. He is not capable of living on his own.

We recently learned about Hyperbaric Oxygen therapy. We were fortunate enough to have the specialist in the field , Dr Paul Harch, treat our son.

So far he has had 40 treatments and we are home in Michigan getting ready to return to New Orleans (where Dr Harch practices). We have seen The Spect scans of our son’s brain-before & after the treatments. There is obviously more blood flow in the brain!! We have also observed changes in his conversational ability and he is more sure of himself. He is "waking up". He is more humorous, assertive, reading more smoothly, is more helpful. We saw “miracles” when we were at the hyperbaric clinic. This treatment would change the lives of the countless innocent babies that have been shaken. The sooner the baby is treated with Hyperbaric Oxygen therapy, the more dramatic the results. These babies could grow up without being blind and mentally challenged.

I am begging you to investigate this therapy for all children that have sustained TBI.

I will check in after the next treatments. Our son’s brain injury is so old, we know he will not regain his full capacity-but he will be able to finish School, hold down a good paying job and raise a family of his own. That is what all parents want for their children: a chance.

A proud mother,

Cynthia